Since its foundation the European Fine Chemicals Group (EFCG) has highlighted the risks and rewards globalisation brings to its members and to pharmaceutical fine chemical industry stakeholders. Guy Villax discusses the options faced by large pharma and regulators alike to meet the challenges of a fast changing industry.
Article / Dec 01, 2008
Risk: assessment, aversion and denial
Scrip 100 (Supplement), December 2008